Literature DB >> 19402778

Calcium dyshomeostasis and neurotoxicity of Alzheimer's beta-amyloid protein.

Masahiro Kawahara1, Midori Negishi-Kato, Yutaka Sadakane.   

Abstract

Neurotoxicity of Alzheimer's beta-amyloid protein (AbetaP) is central to the pathogenesis of Alzheimer's disease (AD). Recent approaches have emphasized the importance of AbetaP oligomerization, which causes synaptic degeneration and neuronal loss, finally leading to the pathogenesis of AD. Although the precise molecular mechanism of AbetaP neurotoxicity remains elusive, our and other numerous findings have demonstrated that AbetaP directly incorporated into neuronal membranes formed calcium-permeable ion channels (amyloid channels) and resulted in an abnormal elevation of the intracellular calcium levels. The formation of amyloid channels and the abnormal increase of intracellular Ca(2+) have also been commonly observed in other neurodegenerative diseases, including conformational diseases such as prion disease or dementia with Lewy bodies. This article reviews the current understanding of the pathology of AD based on the hypothesis that the disruption of calcium homeostasis through amyloid channels may be the molecular basis of AbetaP neurotoxicity. The potential development of preventive agents is also discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19402778     DOI: 10.1586/ern.09.28

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  21 in total

1.  Single-cell screening of cytosolic [Ca(2+)] reveals cell-selective action by the Alzheimer's Aβ peptide ion channel.

Authors:  Hopi Lin; Nelson J Arispe
Journal:  Cell Stress Chaperones       Date:  2014-11-01       Impact factor: 3.667

Review 2.  TRPM channels: same ballpark, different players, and different rules in immunogenetics.

Authors:  Ammad Ahmad Farooqi; Mohammed Khalid Javeed; Zeeshan Javed; Asma M Riaz; Shahzeray Mukhtar; Sehrish Minhaj; Sana Abbas; Shahzad Bhatti
Journal:  Immunogenetics       Date:  2011-09-20       Impact factor: 2.846

3.  Amyloid and Alzheimer's disease.

Authors:  Hongxing Lei
Journal:  Protein Cell       Date:  2010-04       Impact factor: 14.870

4.  Rosuvastatin and thapsigargin modulate γ-secretase gene expression and APP processing in a human neuroglioma model.

Authors:  Alessio Crestini; Paola Piscopo; Mariavittoria Iazeolla; Diego Albani; Roberto Rivabene; Gianluigi Forloni; Annamaria Confaloni
Journal:  J Mol Neurosci       Date:  2010-10-28       Impact factor: 3.444

Review 5.  Amyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer's disease.

Authors:  Tae-In Kam; Youngdae Gwon; Yong-Keun Jung
Journal:  Cell Mol Life Sci       Date:  2014-08-24       Impact factor: 9.261

6.  Dual-energy precursor and nuclear erythroid-related factor 2 activator treatment additively improve redox glutathione levels and neuron survival in aging and Alzheimer mouse neurons upstream of reactive oxygen species.

Authors:  Debolina Ghosh; Kelsey R LeVault; Gregory J Brewer
Journal:  Neurobiol Aging       Date:  2013-08-15       Impact factor: 4.673

7.  TRPM2, calcium and neurodegenerative diseases.

Authors:  Yu-Feng Xie; John F Macdonald; Michael F Jackson
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-03-15

Review 8.  The dysregulation of intracellular calcium in Alzheimer disease.

Authors:  Charlene Supnet; Ilya Bezprozvanny
Journal:  Cell Calcium       Date:  2010-01-18       Impact factor: 6.817

9.  Highly pathogenic H5N1 avian influenza virus induces extracellular Ca2+ influx, leading to apoptosis in avian cells.

Authors:  Mayo Ueda; Tomo Daidoji; Anariwa Du; Cheng-Song Yang; Madiha S Ibrahim; Kazuyoshi Ikuta; Takaaki Nakaya
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

Review 10.  Death by a thousand cuts in Alzheimer's disease: hypoxia--the prodrome.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2013-02-12       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.